Iyengar NM, O'Shaughnessy JA, Moore HB, Hamilton E, et al. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion. NPJ Breast Cancer 2025 Dec 4. doi: 10.1038/s41523-025-00864.
PMID: 41345397